Here are three points:
1. The investment management firm now holds a total of 1.5 million NuVasive shares, valued at $79.7 million.
2. NuVasive reported total revenue of $215.1 million in first quarter of 2016, an 11.8 percent increase from the $192.4 million reported for the first quarter of 2015.
3. The company’s net loss reached $8.9 million for the first quarter 2016.
More articles on devices:
33 organizations implore Congress to postpone CMS equipment proposal: 5 things to know
Simplifying orthopedics in a complex industry — Dr. Joe Kohli changes the game with [m]pirik
InVivo Therapeutics shares mission on radio broadcast — 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
